Paradoxical activation of chronic lymphocytic leukemia cells by ruxolitinib in vitro and in vivo
David Spaner(Sunnybrook Health Science Centre), Yonghong Shi(Hebei Medical University)
Cited by 8
Related Papers
PPARα and fatty acid oxidation mediate glucocorticoid resistance in chronic lymphocytic leukemia
|Blood|2013|97
PPAR-delta promotes survival of breast cancer cells in harsh metabolic conditions
|Oncogenesis|2016|82
Protease-activated receptor-2 promotes kidney tubular epithelial inflammation by inhibiting autophagy via the PI3K/Akt/mTOR signalling pathway
|Biochemical Journal|2017|71
Toll-like Receptor-7 Tolerizes Malignant B Cells and Enhances Killing by Cytotoxic Agents
|Cancer Research|2007|55
Sensitization of IL-2 Signaling through TLR-7 Enhances B Lymphoma Cell Immunogenicity
|The Journal of Immunology|2006|53